Brief: Immuno-Oncology Company Portage Biotech Completes Monetization of Intensity Therapeutics Shares
26/03/2024 12:14
March 26 (Reuters) - Portage Biotech:
* PORTAGE BIOTECH COMPLETES MONETIZATION OF INTENSITY
THERAPEUTICS
(INTS) SHARES
* PORTAGE BIOTECH INC - COMPANY WILL USE PROCEEDS TO FURTHER
FUND
ITS PORT-6 PHASE 1A PORTION OF ADPORT-601 TRIAL
Source text for Eikon: ID:nGNXb9VZb1
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data